Access Bio Statistics

Total Valuation

Access Bio has a market cap or net worth of KRW 164.44 billion. The enterprise value is -222.16 billion.

Market Cap	164.44B
Enterprise Value	-222.16B

Important Dates

The last earnings date was Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Access Bio has 35.17 million shares outstanding. The number of shares has increased by 1.38% in one year.

Current Share Class	n/a
Shares Outstanding	35.17M
Shares Change (YoY)	+1.38%
Shares Change (QoQ)	+2.88%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.27%
Float	26.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.42
PB Ratio	0.25
P/TBV Ratio	0.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	639.16
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.44

Financial Position

The company has a current ratio of 12.38, with a Debt / Equity ratio of 0.10.

Current Ratio	12.38
Quick Ratio	11.49
Debt / Equity	0.10
Debt / EBITDA	8.83
Debt / FCF	3.70
Interest Coverage	-3.63

Financial Efficiency

Return on equity (ROE) is -0.17% and return on invested capital (ROIC) is -1.14%.

Return on Equity (ROE)	-0.17%
Return on Assets (ROA)	-1.10%
Return on Invested Capital (ROIC)	-1.14%
Return on Capital Employed (ROCE)	-1.80%
Revenue Per Employee	1.11B
Profits Per Employee	-3.44M
Employee Count	101
Asset Turnover	0.16
Inventory Turnover	2.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.33% in the last 52 weeks. The beta is 0.11, so Access Bio's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-37.33%
50-Day Moving Average	5,349.30
200-Day Moving Average	6,167.28
Relative Strength Index (RSI)	27.01
Average Volume (20 Days)	69,811

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Access Bio had revenue of KRW 112.46 billion and -347.58 million in losses. Loss per share was -10.15.

Revenue	112.46B
Gross Profit	53.27B
Operating Income	-12.60B
Pretax Income	-143.86M
Net Income	-347.58M
EBITDA	7.48B
EBIT	-12.60B
Loss Per Share	-10.15

Full Income Statement

Balance Sheet

The company has 454.85 billion in cash and 66.00 billion in debt, giving a net cash position of 388.85 billion or 11,055.01 per share.

Cash & Cash Equivalents	454.85B
Total Debt	66.00B
Net Cash	388.85B
Net Cash Per Share	11,055.01
Equity (Book Value)	652.41B
Book Value Per Share	18,483.97
Working Capital	459.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.90 billion and capital expenditures -2.05 billion, giving a free cash flow of 17.85 billion.

Operating Cash Flow	19.90B
Capital Expenditures	-2.05B
Free Cash Flow	17.85B
FCF Per Share	507.57

Full Cash Flow Statement

Margins

Gross margin is 47.36%, with operating and profit margins of -11.21% and -0.31%.

Gross Margin	47.36%
Operating Margin	-11.21%
Pretax Margin	-0.13%
Profit Margin	-0.31%
EBITDA Margin	6.65%
EBIT Margin	-11.21%
FCF Margin	15.87%

Dividends & Yields

Access Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.38%
Shareholder Yield	-1.38%
Earnings Yield	-0.21%
FCF Yield	10.86%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Access Bio has an Altman Z-Score of 3.66.

Altman Z-Score	3.66
Piotroski F-Score	n/a